Aug 19 (Reuters) - CSPC Pharmaceutical Group Ltd :
* CSPC INNOVATION PHARMACEUTICAL HY NET PROFIT ATTRIBUTABLE RMB155.1 MILLION VERSUS RMB152.9 MILLION
* HY REVENUE OF CSPC INNOVATION PHARMA RMB 707.4 MILLION VERSUS RMB 687.2 MILLION
Source text for Eikon: Further company coverage:
(Reuters.Briefs@thomsonreuters.com)
精彩评论